drugset / Trial / NCT00780026

Intraoperative Glucose Control in Liver Transplant

NCT00780026

Phase 4 Completed 100 enrolled University of Michigan
RandomizedParallel-groupOpen-labelSupportive care

Summary

The goal of the proposed study is to evaluate the effectiveness of intraoperative, strict glycemic control to improve survival and infection rates following liver transplantation in a randomized, prospective trial.Primary objective: To determine if strict intraoperative blood glucose control, when compared to standard intraoperative glycemic control, improves 1-year recipient survival and decreases surgical complications, including infections, following liver transplantation.

Timeline

Start
2008-07
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic

Indications

No indication recorded.